Today's announcement was actually for PD1-Vaxx and not HER-Vaxx. It's my understanding is that PD1-Vaxx is based on the same delivery method as HER-Vaxx using B cells to provoke a vaccine/immune response but the difference is that the drugs target different sites in the cells.
So, IMU has 4 potentially major drugs in the pipeline (HER-Vaxx, PD1-Vaxx, CheckVacc and Vaxinnia). I believe today's announcement was more a reminder of the diversity of the pipeline and the broader application of the B cell platform.
If all 4 were to be a success, what price would you put on a company with 4 drugs that would snare a fair chunk of what is likely to be a $200 billion market by 2026? Plus further opportunities that could be developed if the B Cell Platform works as hoped.
- Forums
- ASX - By Stock
- Ann: New mimotope cancer vaccine results published
Today's announcement was actually for PD1-Vaxx and not HER-Vaxx....
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $356.9M |
Open | High | Low | Value | Volume |
4.9¢ | 4.9¢ | 4.8¢ | $328.5K | 6.792M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
45 | 5443565 | 4.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.9¢ | 2171910 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
36 | 4613688 | 0.048 |
36 | 4066646 | 0.047 |
46 | 3070983 | 0.046 |
60 | 6170008 | 0.045 |
11 | 1951364 | 0.044 |
Price($) | Vol. | No. |
---|---|---|
0.049 | 1200533 | 2 |
0.050 | 4130537 | 15 |
0.051 | 6179811 | 13 |
0.052 | 2579418 | 10 |
0.053 | 1158504 | 8 |
Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
Featured News
NEWS
Breakthrough programs slash healthcare events, driving a significant A$1.8M+ annual revenue boost
CC9
Chariot Corporation (ASX:CC9) refines Black Mountain strategy, launching Pilot Mine to seize U.S. lithium opportunity
IMU (ASX) Chart |